ISRCTN77249875CompletedNot Applicable
Objective assessment of the remission state and Predictors of sustained Remission in Rheumatoid Arthritis: leading to development of new management guidelines
niversity of Leeds (UK)0 sites100 target enrollmentStarted: April 30, 2007Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Aged over 18 years
- •2. Male or female
- •3. American College of Rheumatology (ACR) diagnosis of rheumatoid arthritis
- •4. Stable Tumor Necrotising Factor (TNF) antagonist and concomitant Disease Modifying Anti-Rheumatic Drugs (DMARDs) (e.g. methotrexate treatment for six months)
- •5. Clinical remission for six months (at time of screening) as defined by Disease Activity Score (DAS28) less than 2.6
- •6. No clinical indication to change current treatment
Exclusion Criteria
- •1. Patients who are unwilling or unable to give consent
- •2. Patients who are pregnant
Investigators
Similar Trials
Completed
Phase 4
Evaluation of the clinical remission and its sustainment after discontinuation of infliximab in patients with rheumatoid arthritis who receive "programmed" treatment in randomized controlled trialRheumatoid ArthritisJPRN-UMIN000005113niversity of Occupational and Environmental Health, Japan450
Not yet recruiting
Not Applicable
Examination of the clinical remission and functional remission in Infliximab using the increase-in-quantity protocol to TNF-alpha inhibitory drug resistance rheumatoid arthritisrheumatoid arthritisJPRN-UMIN000014311Institute of Health Biosciences, The University of Tokushima Graduate School10
Completed
Not Applicable
The evaluation of efficacy for remission maintenance with immunomodulator following remission induction with tacrolimus in patients with moderate to severe active refractory ulcerative colitis.:mucosal healing for prognosisThe patients with moderate to severe active refractory ulcerative colitisJPRN-UMIN000004201Osaka City University, Graduate School of Medicine,Department of Gastroenterology50
Active, not recruiting
Not Applicable
A 3-Phase Study to Evaluate Sustained Remission and Productivity Outcomes in Subjects With Early Rheumatoid Arthritis Initiated on Treatment With Etanercept Plus Methotrexate - PRIZEModerate to severe early Rheumatoid Arthritis (RA).MedDRA version: 12.0Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2008-002623-85-ITWyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development300
Active, not recruiting
Not Applicable
QALY (Quality adjusted life years) post Coronary bypass surgeryCTRI/2022/12/048576arayana Health City